From how Asian countries can reclaim their ‘genetic destiny’ to an exploration of the ethnic differences in disease like cancer, diabetes and Hepatitis C, to some of the most exciting thematics including molecular diagnostics technology as well as cell and gene therapies, to spotlights on some of the most intrepid and innovative companies in the…
InFocus
This inaugural edition of the InFocus Five Biotechs To Watch in China has selected companies at different stages of the biotech journey in order to showcase the diverse and multifaceted nature of Chinese biopharma innovation. While these companies are no doubt bound by a number of similarities, it is the differences that make their individual…
Produced in association with Novartis, InFocus Cell & Gene Therapy examines the remarkable progress of cell and gene therapies in recent years. Fast turning into a powerful engine of value creation for drug makers and representing a paradigm shift in the treatment of some of the world’s most devastating and intractable illnesses, in the last…
Long regarded as a neglected backwater within the drug discovery landscape and the preserve of only a handful of niche players, the rare disease space has been undergoing an extraordinary turnaround in fortunes of late. This special report delves into the flurry of activity taking place across the rare disease and orphan drug sector…
While drug developers, healthcare practitioners and patients all rejoice at the advent of a golden age of scientific advancement in medicine – symbolized by recent radical breakthroughs in all manners of domains from stem cells and CAR-T generation immunotherapy to gene tech and 3D bio-printing – it is clear that regulatory science has struggled to…
2017 was a comparatively quiet year for pharma M&A. However, conditions remain ripe for companies to engage in more deal making in 2018. Big Pharma is divesting its non-core assets and doubling down on core business lines. Furthermore, generics portfolios are increasingly being seen as underperforming assets that distract from the bread and butter of…
As pharmaceutical and biotech products become more complex and the markets they serve more diverse, the healthcare logistics and distribution industry has had to consistently innovate and evolve to meet the needs of its clients. This report focuses on how this important niche has evolved and what the future holds through interviews with some of…
This report offers companies, investors, policymakers, and stakeholders in-depth analysis of the benefits of blockchain technology in general and BioIPSeeds in particular, as well as expert insights into this game-changing technological breakthrough. The report features in-depth exclusive interviews with the developers of BioIPSeeds, as well as key opinion leaders who weigh in on the…
